Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Tilray's Broken Coast Launches New Summer Lineup Of Cannabis Products

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) is expanding Broken Coast’s cannabis portfolio with the launch of their summer lineup of products, including: premium craft-cannabis BC (British Columbia) flower, liquid wax vapes and butane hash o

Benzinga

Why Acorda Therapeutics Shares Gaining Today?

Acorda Therapeutics Inc (NASDAQ:ACOR) announced that Esteve Pharmaceuticals GmbH launched INBRIJA 33 mg (levodopa inhalation powder, hard capsules) in Germany. INBRIJA is indicated in the EU for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson's disease treated with a levodopa/dopa-decarboxylase inhibitor. Under the distribution and supply agreements, Acorda…

Benzinga

HEXO's Shareholders Approve Standby Commitment Transaction

On the special meeting of shareholders of HEXO Corp (NASDAQ: HEXO) (TSX:HEXO), holders of common shares of HEXO overwhelmingly approved the equity purchase agreement

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Akero Therapeutics Shares Surge After Equity Investment From This Famed Large Cap Biopharma

Akero Therapeutics Inc (NASDAQ:AKRO) announced a $25 million equity investment by Pfizer Inc (NYSE:PFE) at $9.90 per share. The company also announced a term loan facility providing Akero with access to up to $100 million from Hercules Capital Inc (NYSE:HTGC), of which $10 million will be drawn at transaction close. Together with existing cash, proceeds will support…

Benzinga

What 24 Analyst Ratings Have To Say About Meta Platforms

Within the last quarter, Meta Platforms (NASDAQ:META) has observed the following analyst ratings:

Benzinga

What 6 Analyst Ratings Have To Say About Olaplex Hldgs

Within the last quarter, Olaplex Hldgs (NASDAQ:OLPX) has observed the following analyst ratings:

Benzinga

Peering Into Enphase Energy's Recent Short Interest

Enphase Energy's (NASDAQ:ENPH) short percent of float has risen 7.74% since its last report. The company recently reported that it has 4.39 million shares sold short, which is 3.34% of all regular shares that are available for trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Key Takeaways From Apple's Antitrust Lawsuit In UK

Market researcher Justin Gutmann prosecuted Apple Inc (NASDAQ:AAPL) on behalf of the U.K. iPhone users for allegedly misleading customers on a controversial power management tool, Bloomberg reports. Gutmann alleged Apple abused its influence to conceal a power management tool in the updates to hide the phone batteries' inefficiency in handling the new software's…

Benzinga

Twitter's Employees Can't Go To 'The Happiest Place On Earth' In 2023, Cost Cutting Measures Hit Company Travel

Twitter Inc (NYSE:TWTR) is ditching a companywide retreat scheduled for January 2023 at Walt Disney Company (NYSE:DIS) Disneyland - 'The Happiest Place On Earth,' Bloomberg reports. Twitter cited cost-cutting measures to reduce corporate travel behind the move. The company's occasional gathering, known as 'OneTeam,' was last held in early 2020 in Houston before the…

Benzinga

Jim Cramer Says This Company Is A Great One

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Woodside Energy Group Ltd (NYSE: WDS) is a great company, with a great yield.

Benzinga

Benzinga Before The Bell: Tesla Raises Prices, Revlon Goes Bankrupt And Other Top Financial Stories Thursday, June 16

Wall Street Journal Moderna Plans COVID-19 Vaccine Trial For Infants

Benzinga

Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients

Roche Holdings AG (OTC:RHHBY) said its Alzheimer's medicine crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation that causes early-onset disease. Crenezumab did not show a statistically significant clinical benefit in its co-primary endpoints assessing the rate of change in cognitive abilities or episodic memory function. The…

Benzinga

Tesla Model 3 Tops List Of Most Loved Cars By Customers Globally In New Study

Tesla Inc (NASDAQ: TSLA) ranks first among a list of 50 top-selling cars across the globe that tracks the happiness index of owners, according to Zutobi, a Swedish online driver education firm.

Benzinga

3 Stocks Under $3 Insiders Are Aggressively Buying

The Federal Open Market Committee opted to raise fed funds rates by 0.75% on Wednesday to a new target range of between 1.5% and 1.75%. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Nike And 3 Other Stocks Insiders Are Selling

US stock futures traded lower this morning on Thursday after recording gains in the previous session. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Coinbase To Lay Off 8% Of India Team — But Makes This Key Top-Level Hire

Coinbase Inc (NASDAQ: COIN), which curtailed its Indian operations within three days of opening, has now laid off nearly 8% of its workforce in the country as part of its global cost-cutting strategy.

Benzinga

French Regulator Reaches Truce With Facebook Owner Meta Over Online Ads

France's antitrust watchdog body approved Facebook owner Meta Platforms Inc's (NASDAQ:META) obligations regarding the French online advertising sector. Meta had committed to giving access over five years to advertising inventories and campaign data to adtech companies on 'transparent, objective and predictable' conditions. The watchdog's investigation services raised competition concerns about multiple practices by Meta…

Benzinga

Flora Growth To Repurchase Up To $5M Worth Of Shares

Flora Growth Corp.’s (NASDAQ: FLGC) board of directors has authorized the repurchase of up to $5 million of its outstanding common shares as market conditions and the company’s liquidity warrant.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Aquestive Therapeutics Reveals Favorable Data From Epinephrine Trial For Allergies

Aquestive Therapeutics Inc (NASDAQ:AQST) announced topline results from the first three arms of Part 3 of the EPIPHAST study for its AQST-109 epinephrine oral film for allergic reactions, including anaphylaxis. In the first three arms of Part 3, AQST-109 12 mg continued to show rapid absorption with favorable pharmacokinetics. The median time to…

Benzinga

Insiders Buy More Than $57M Of 2 Stocks

Although the Dow Jones jumped more than 300 points on Wednesday, there were a few notable insider trades.

Benzinga

Moderna Plans COVID-19 Vaccine Trial For Infants: WSJ

Moderna Inc (NASDAQ: MRNA) is reportedly planning to evaluate its COVID-19 vaccine in infants aged three months to 6 months.

Benzinga

Elon Musk Wants To Be 'Let In' Somewhere This Halloween, Disguised As A 'Sink'

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk wants to dress up as a sink for Halloween, according to a recent social media post. What Happened: Musk tweeted, “I’m dressing as a sink on Halloween, as they will have no choice but to let me in.”

Benzinga

27 Stocks Moving in Thursday's Pre-Market Session

Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) rose 92.9% to $3.28 in pre-market trading following’s Wednesday IPO.

Benzinga

Spotify Slows Down On Hiring Amid Macro Uncertainties

Spotify Technology S.A. (NYSE:SPOT) slowed hiring by 25%, CNBC reports based on a companywide email from CEO Daniel Ek. However, he added the company would “continue to still hire and grow, we are just going to slow that pace and be a bit more prudent with the absolute level of new hires over…

Benzinga

Apple Could Be Bringing 15-Inch M2 MacBook Within A Year

Apple Inc (NASDAQ: AAPL) could come up with a new 15” MacBook model which could sport its latest M2 and M2 Pro Chips.

1 … 377 378 379 380

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations